1. Home
  2. BHR vs TLSA Comparison

BHR vs TLSA Comparison

Compare BHR & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Braemar Hotels & Resorts Inc.

BHR

Braemar Hotels & Resorts Inc.

N/A

Current Price

$1.65

Market Cap

127.7M

Sector

Real Estate

ML Signal

N/A

Logo Tiziana Life Sciences Ltd.

TLSA

Tiziana Life Sciences Ltd.

N/A

Current Price

$1.14

Market Cap

145.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BHR
TLSA
Founded
2013
2013
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
127.7M
145.1M
IPO Year
2013
2017

Fundamental Metrics

Financial Performance
Metric
BHR
TLSA
Price
$1.65
$1.14
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
★ $7.97
AVG Volume (30 Days)
426.1K
★ 545.0K
Earning Date
11-04-2026
05-01-2026
Dividend Yield
★ 2.99%
N/A
EPS Growth
N/A
★ N/A
EPS
★ 0.06
N/A
Revenue
★ $487,614,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$28.00
★ N/A
Revenue Growth
★ 13.03
N/A
52 Week Low
$1.64
$0.76
52 Week High
$3.19
$2.33

Technical Indicators

Market Signals
Indicator
BHR
TLSA
Relative Strength Index (RSI) 25.65 59.09
Support Level N/A $0.90
Resistance Level $2.63 $1.20
Average True Range (ATR) 0.05 0.09
MACD -0.01 0.02
Stochastic Oscillator 3.77 94.69

Price Performance

Historical Comparison
BHR
TLSA

About BHR Braemar Hotels & Resorts Inc.

Braemar Hotels & Resorts Inc is a real estate investment trust company that invests in high revenue per available room, or RevPAR, luxury hotels and resorts. The firm operates in various U.S. states such as California, Texas, Washington, Philadelphia, Florida, and Illinois as well as Washington, D.C. and St. Thomas, U.S. Virgin Islands. The company operates through its direct hotel investment segment of the hotel lodging industry. Its revenue streams include rooms, food and beverage, and other. The firm's hotels operate under various brands, such as Marriott, Hilton, Courtyard, and, among others.

About TLSA Tiziana Life Sciences Ltd.

Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. The company's clinical pipeline includes drug assets for Non-Active Secondary Progressive Multiple Sclerosis, Multiple System Atrophy, Alzheimer's, and Amyotrophic Lateral Sclerosis. The company's mission is to design and deliver next-generation immunotherapies for neurodegenerative and neuroinflammatory diseases. The company's main immunotherapeutic candidate, Foralumab (TZLS-401), is being developed for Non-Active Secondary Progressive Multiple Sclerosis, Alzheimer's, and other CNS indications.

Share on Social Networks: